Identification of DBC1 as a transcriptional repressor for BRCA1

Background:DBC1/KIAA1967 (deleted in breast cancer 1) is a putative tumour-suppressor gene cloned from a heterozygously deleted region in breast cancer specimens. Caspase-dependent processing of DBC1 promotes apoptosis, and depletion of endogenous DBC1 negatively regulates p53-dependent apoptosis through its specific inhibition of SIRT1. Hereditary breast and ovarian cancer susceptibility gene product BRCA1, by binding to the promoter region of SIRT1, is a positive regulator of SIRT1 expression.Methods:A physical interaction between DBC1 and BRCA1 was investigated both in vivo and in vitro. To determine the pathophysiological significance of DBC1, its role as a transcriptional factor was studied.Results:We found a physical interaction between the amino terminus of DBC1 and the carboxyl terminus of BRCA1, also known as the BRCT domain. Endogenous DBC1 and BRCA1 form a complex in the nucleus of intact cells, which is exported to the cytoplasm during ultraviolet-induced apoptosis. We also showed that the expression of DBC1 represses the transcriptional activation function of BRCT by a transient expression assay. The expression of DBC1 also inhibits the transactivation of the SIRT1 promoter mediated by full-length BRCA1.Conclusion:These results revealed that DBC1 may modulate the cellular functions of BRCA1 and have important implications in the understanding of carcinogenesis in breast tissue.

• Publication year

  2010

• Venue

  British Journal of Cancer

• Publication date

  2010-02-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.bjc.6605577PMID 20160719PMCID 2844029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Repression of estrogen receptor beta function by putative tumor suppressor DBC1.

  2010cited by this paper
• Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma

  2009cited by this paper
• Negative regulation of the deacetylase SIRT1 by DBC1

  2008influential reference
• DBC1 is a negative regulator of SIRT1

  2008cited by this paper
• Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.

  2008influential reference
• SIRT1 promotes DNA repair activity and deacetylation of Ku70

  2007cited by this paper
• An hGCN5/TRRAP Histone Acetyltransferase Complex Co-activates BRCA1 Transactivation Function through Histone Modification*

  2006cited by this paper
• Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta-/- mice.

  2006cited by this paper
• Role of estrogen receptor β in uterine stroma and epithelium: Insights from estrogen receptor β−/− mice

  2006cited by this paper
• Signalling DNA Damage by Regulating p53 Co-factor Activity

  2005cited by this paper
• Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling

  2005influential reference
• BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220

  2004cited by this paper
• DBC2, a candidate for a tumor suppressor gene involved in breast cancer

  2002cited by this paper
• Caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosis

  2002cited by this paper
• A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage

  2001influential reference
• Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.

  2001cited by this paper
• A Functional Comparison of BRCA1 C-terminal Domains in Transcription Activation and Chromatin Remodeling*

  2000cited by this paper
• BRCA1 activation of the GADD45 promoter

  2000cited by this paper
• BRCA1 signals ARF-dependent stabilization and coactivation of p53

  1999cited by this paper
• Brca1 controls homology-directed DNA repair.

  1999cited by this paper
• BRCA1 interacts with components of the histone deacetylase complex.

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• BRCA1 regulates p53-dependent gene expression.

  1998cited by this paper
• BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A

  1998cited by this paper
• From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair

  1997cited by this paper
• Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing.

  1997influential reference
• A superfamily of conserved domains in DNA damage‐ responsive cell cycle checkpoint proteins

  1997cited by this paper
• Damage and replication checkpoint control in fission yeast is ensured by interactions of Crb2, a protein with BRCT motif, with Cut5 and Chk1.

  1997cited by this paper
• BRCA1 is a component of the RNA polymerase II holoenzyme.

  1997cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996influential reference

• Multimodal bHLH-PAS DNA binding controls specificity and drives obesity

  2026cites this paper
• Analysis of Transcriptome and Differentially Expressed Genes in Chicken Primordial Germ Cells

  2026cites this paper
• Adipocyte-specific deletion of Dbc1 does not recapitulate healthy obesity phenotype but suggests regulation of inflammation signaling

  2025cites this paper
• Multifaceted roles of CCAR family proteins in the DNA damage response and cancer

  2024cites this paper
• Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma

  2024cites this paper
• Molecular mechanism of NAD+ and NMN binding to the Nudix homology domains of DBC1.

  2024cites this paper
• Mechanistic insights into the dual role of CCAR2/DBC1 in cancer

  2023cites this paper
• Molecular mechanism of NAD+ binding to the Nudix homology domains of DBC1

  2023cites this paper
• SUMO1-regulated DBC1 promotes p53-dependent stress-induced apoptosis of lens epithelial cells

  2023cites this paper
• Impaired hippocampal neurogenesis and cognitive performance in adult DBC1-knock out mice.

  2022cites this paper
• ML216 Prevents DNA Damage-Induced Senescence by Modulating DBC1–BLM Interaction

  2022cites this paper
• Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology.

  2022cites this paper
• MED1, a novel binding partner of BRCA1, regulates homologous recombination and R-loop processing

  2022cites this paper
• Core and Flanking bHLH-PAS:DNA interactions mediate specificity and drive obesity

  2022cites this paper
• Interaction of DBC1 with polyoma small T antigen promotes its degradation and negatively regulates tumorigenesis

  2021cites this paper
• Mechanism of tumor synthetic lethal-related targets

  2021cites this paper
• The protein Deleted in Breast Cancer-1 (DBC1) regulates vascular response and formation of aortic dissection during Angiotensin II infusion

  2020cites this paper
• DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

  2020cites this paper
• Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.

  2019cites this paper
• DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination

  2019cites this paper
• Regulation of anoikis by oncogenic pathways

  2019cites this paper
• Deleted in Breast Cancer 1 as a Novel Prognostic Biomarker for Digestive System Cancers: A Meta-Analysis

  2019cites this paper
• Regulation of resection by chromatin associated proteins

  2019cites this paper
• Integrative Analysis of Cancer Omics Data for Prognosis Modeling

  2019cites this paper
• A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo

  2019cites this paper
• NANOGP8 expression regulates gastric cancer cell progression by transactivating DBC1 in gastric cancer MKN-45 cells.

  2018cites this paper
• Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology.

  2018cites this paper
• Loss of DBC1 (CCAR2) affects TNFα-induced lipolysis and Glut4 gene expression in murine adipocytes.

  2018cites this paper
• Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication.

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Identificación de nuevas proteínas que interaccionan con CtIP: Implicación de PRMT5 y CCAR2 en la resección del ADN

  2017cites this paper
• Hereditary Pancreatic Cancer

  2017cites this paper
• A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection

  2016cites this paper
• HAND2-mediated proteolysis negatively regulates the function of estrogen receptor α.

  2015cites this paper
• DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of

  2015cites this paper
• Cancer-predisposition gene KLLN maintains pericentric H3K9 trimethylation protecting genomic stability

  2015cites this paper
• DBC1 Functions as a Tumor Suppressor by Regulating p53 Stability

  2015cites this paper
• Running Title: Regulatory roles of DBC1 revealed by protein interactions

  2015cites this paper
• Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation

  2015cites this paper
• The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma

  2015influential citation
• DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-κB activity.

  2015cites this paper
• CCAR2 negatively regulates nuclear receptor LXRα by competing with SIRT1 deacetylase.

  2015influential citation
• CK2α phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients

  2015cites this paper
• DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcoma

  2015cites this paper
• MCC inhibits beta‐catenin transcriptional activity by sequestering DBC1 in the cytoplasm

  2015cites this paper
• The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression*

  2015cites this paper
• Identification of KSR1 as a novel target and decoding tyrosine kinase proteome in breast cancer

  2014cites this paper
• DBC1 is over-expressed and associated with poor prognosis in colorectal cancer

  2014cites this paper
• CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells

  2014cites this paper
• Distinct, genome-wide, gene-specific selectivity patterns of four glucocorticoid receptor coregulators

  2014cites this paper
• SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer

  2014cites this paper
• A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer

  2014cites this paper
• Deleted in Breast Cancer 1 Limits Adipose Tissue Fat Accumulation and Plays a Key Role in the Development of Metabolic Syndrome Phenotype

  2014cites this paper
• Transcriptional Activity B κ Negatively Regulating Alternative NF-DBC 1 Is a Suppressor of B Cell Activation by and Deyu

  2014cites this paper
• BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer

  2014cites this paper
• KSR1 regulates BRCA1 degradation and inhibits breast cancer growth

  2014cites this paper
• A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer

  2014cites this paper
• DBC1 Is a Suppressor of B Cell Activation by Negatively Regulating Alternative NF-κB Transcriptional Activity

  2014cites this paper
• B κ Negatively Regulating Alternative NF- DBC1 Is a Suppressor of B Cell Activation by

  2014cites this paper
• Role of multifunctional transcription factor TFII-I and putative tumour suppressor DBC1 in cell cycle and DNA double strand damage repair

  2013cites this paper
• Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients

  2013cites this paper
• Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer

  2013cites this paper
• Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB

  2013cites this paper
• Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas

  2013cites this paper
• High SIRT1 expression and low DBC1 expression are associated with poor prognosis in colorectal cancer

  2013cites this paper
• DBC1 (Deleted in Breast Cancer 1) modulates the stability and function of the nuclear receptor Rev-erbα

  2013cites this paper
• Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.

  2013cites this paper
• A Functional Proteomics Perspective of DBC1 as a Regulator of Transcription.

  2013cites this paper
• DBC 1 ( Deleted in Breast Cancer 1 ) modulates the stability and function of the nuclear receptor Reverb α

  2013cites this paper
• Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.

  2013cites this paper
• Molecular characterization, alternative splicing and expression analysis of bovine DBC1.

  2013cites this paper
• Role of Deleted in Breast Cancer 1 (DBC1) Protein in SIRT1 Deacetylase Activation Induced by Protein Kinase A and AMP-activated Protein Kinase*

  2012cites this paper
• Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary

  2012cites this paper
• Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression.

  2012cites this paper
• The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

  2012cites this paper
• Multifunctional transcription factor TFII-I is an activator of BRCA1 function

  2011cites this paper
• Expression of DBC 1 is associated with nuclear grade and HER 2 expression in breast cancer

  2011cites this paper
• Reciprocal roles of DBC 1 and SIRT 1 in regulating estrogen receptor a activity and coactivator synergy

  2011cites this paper
• Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.

  2011cites this paper
• Proteomic Analysis of Pathways Involved in Estrogen-Induced Growth and Apoptosis of Breast Cancer Cells

  2011cites this paper
• Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy

  2011cites this paper
• The LIM Protein Zyxin Binds CARP-1 and Promotes Apoptosis.

  2010cites this paper
• DBC 1 promotes anoikis resistance of gastric cancer cells by regulating NF-κ B activity

  year unknowncites this paper